Practice Guideline
doi: 10.3904/kjim.2014.29.1.132.
Epub 2014 Jan 2.
Severe influenza treatment guideline
Affiliations
- PMID: 24574848
- PMCID: PMC3932389
- DOI: 10.3904/kjim.2014.29.1.132
Item in Clipboard
Practice Guideline
Severe influenza treatment guideline
Korean J Intern Med.
2014 Jan.
No abstract available
Conflict of interest statement
No potential conflict of interest relevant to this article is reported.
Similar articles
-
[Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].Med Intensiva. 2012 Mar;36(2):103-37. doi: 10.1016/j.medin.2011.11.020. Epub 2012 Jan 13. Med Intensiva. 2012. PMID: 22245450 Spanish.
-
[Clinical course of severe influenza-A/H1N1 infection with fulminant lung failure].Dtsch Med Wochenschr. 2010 Jan;135(1-2):40-2. doi: 10.1055/s-0029-1244816. Epub 2009 Dec 18. Dtsch Med Wochenschr. 2010. PMID: 20024884 German. No abstract available.
-
The first novel influenza A (H1N1) fatality despite antiviral treatment and extracorporeal membrane oxygenation in Hong Kong.Hong Kong Med J. 2009 Oct;15(5):381-4. Hong Kong Med J. 2009. PMID: 19801697
-
Use of Extracorporeal Membrane Oxygenation for the Treatment of Influenza-Induced Acute Respiratory Distress Syndrome in Immunocompromised Adults.Am J Med Sci. 2016 Jul;352(1):81-5. doi: 10.1016/j.amjms.2016.03.021. Epub 2016 Apr 12. Am J Med Sci. 2016. PMID: 27432039 Review.
-
Extracorporeal membrane oxygenation in the context of the 2009 H1N1 influenza A pandemic.Surg Infect (Larchmt). 2011 Apr;12(2):151-8. doi: 10.1089/sur.2010.082. Surg Infect (Larchmt). 2011. PMID: 21545282 Review.
Cited by
-
Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug-disease modelling for dosing regimen optimization.Br J Clin Pharmacol. 2021 Mar;87(3):1359-1368. doi: 10.1111/bcp.14523. Epub 2020 Sep 9. Br J Clin Pharmacol. 2021. PMID: 32808306 Free PMC article.
-
Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.Clin Immunol. 2021 Feb;223:108652. doi: 10.1016/j.clim.2020.108652. Epub 2020 Dec 14. Clin Immunol. 2021. PMID: 33333256 Free PMC article. Review.
-
Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection.Sci Rep. 2016 Jul 6;6:29154. doi: 10.1038/srep29154. Sci Rep. 2016. PMID: 27380890 Free PMC article.
-
Mammalian Target of Rapamycin Complex 1 Activation in Macrophages Contributes to Persistent Lung Inflammation following Respiratory Tract Viral Infection.Am J Pathol. 2024 Mar;194(3):384-401. doi: 10.1016/j.ajpath.2023.11.017. Epub 2023 Dec 28. Am J Pathol. 2024. PMID: 38159723 Free PMC article.
-
Influenza and Aging: Clinical Manifestations, Complications, and Treatment Approaches in Older Adults.Drugs Aging. 2025 Jan;42(1):39-55. doi: 10.1007/s40266-024-01169-y. Epub 2025 Jan 7. Drugs Aging. 2025. PMID: 39775605 Review.
References
-
- Choi WS, Lee J, Lee HY, et al. Clinical practice guideline for antiviral treatment and chemoprophylaxis of seasonal influenza. Infect Chemother. 2012;44:233–249.
-
- World Health Organization. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses [Internet] Geneva (CH): World Health Organization; c2013. [cited 2013 Oct 2]. Available from: http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivira...
-
- Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA. 1999;282:1240–1246. - PubMed
-
- Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute inf luenza: a randomised controlled trial: Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet. 2000;355:1845–1850. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
